* Read the article on page 124.
* Take the test, recording your answers in the test answers section (Section B) of the CE enrollment form. Each question has only one correct answer.
* Complete registration information (Section A) and course evaluation (Section C).
* Mail completed test with registration fee to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723.
* Within 4-6 weeks after your CE enrollment form is received, you will be notified of your test results.
* If you pass, you will receive a certificate of earned contact hours and answer key. If you fail, you have the option of taking the test again at no additional cost.
* A passing score for this test is 14 correct answers.
* Need CE STAT? Visit www.nursingcenter.com for immediate results, other CE activities, and your personalized CE planner tool.
* No Internet access? Call 1-800-787-8985 for other rush service options.
* Questions? Contact Lippincott Williams & Wilkins: 1-800-787-8985.
Registration Deadline: June 30, 2011
The authors have disclosed that they have no significant relationship with or financial interest in any commercial companies that pertain to this educational activity.
Lippincott Williams & Wilkins, publisher of Journal of Neuroscience Nursing, will award 1.0 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454. LWW home study activities are classified for Texas nursing continuing education requirements as Type 1. Your certificate is valid in all states.
Payment and Discounts:
* The registration fee for AANN members is $6.50; for nonmembers, $12.95.
* AANN members-to get the discounted price (50% off) when taking the test online, log into the secure "Members Only" area of www.aann.org to get the discount code. Use the code when paying for CE courses on www.nursingcenter.com/CE/JNN.
* If you take two or more tests in any nursing journal published by LWW and send in your CE enrollment forms together, you may deduct $0.95 from the price of each test.
* We offer special discounts for as few as six tests and institutional bulk discounts for multiple tests. Call 1-800-787-8985 for more information.
CE TEST QUESTION
GENERAL PURPOSE OF THE CE ACTIVITY: To familiarize the registered professional nurse with the incidence, pathology, and care of patients with meningiomas.
LEARNING OBJECTIVES: After reading this article and taking the test, the nurse will be able to:
1. Discuss the incidence, pathology, and diagnosis of patients with meningiomas.
2. Describe medical and nursing management of patients with meningiomas.
1. Which statement about meningiomas is not correct?
a. They are the most common primary brain tumor.
b. They account for about 30% of primary neoplasms.
c. They often present with generalized symptoms such as headache or seizures.
d. Differentiating low-grade from high-grade meningiomas on MRI is often difficult.
2. Which population is most likely to develop a menigioma?
a. male children
b. female children
c. men 40-70 years old
d. women 40-70 years old
3. The World Health Organization classifies meningiomas into
a. two grades.
b. three grades.
c. four grades.
d. six grades.
4. Studies seeking to discover factors that contribute to menigioma
a. clearly indicate occupational exposure to radiation is a predisposing factor.
b. clearly indicate a relationship with elevated estrogen levels and previous head trauma.
c. have ruled out a relationship with neurofibromatosis.
d. are not conclusive about predisposing factors.
5. Which statement about diagnosing meningiomas is correct?
a. They have distinct features that show on an MRI.
b. They have distinct features that show on CT scans.
c. They are difficult to diagnose with imaging tests.
d. They can only be definitively diagnosed during neurosurgery.
6. The tumor having the best prognosis after surgery is one with a
a. proliferation rate of <1%.
b. proliferation rate of >5%.
c. mitotic activity rate of 10.
d. mitotic activity rate of 20.
7. Which pathological feature is not characteristic of aggressive tumor behavior?
a. prominent nucleoli
b. enhanced lobularity
c. small cells
d. increased cellularity
8. Grade II tumors are also classified as
a. benign tumors.
b. atypical tumors.
c. anaplastic tumors.
d. rhabdoid tumors.
9. Which tumor is most likely to invade the brain?
a. Grade I
b. Grade II
c. Grade III
d. Grade IV
10. Which is not one of the most common sites of metastasis?
11. The tumors that are most likely to recur are tumors located
a. at the convexity and suprasellar areas.
b. at the sphenoid wing or dural sinuses.
c. along the olfactory groove or optic sheath.
d. within the intraventricular or posterior fossa.
12. Radiation therapy is most likely to be needed for a
a. Grade I meningioma.
b. Grade I meningioma postoperatively.
c. Grade II meningioma after surgical debulking.
d. Grade III meningioma with no obvious postoperative residual tumor.
13. The usual course of radiation therapy for meningioma is
a. 3 days a week for about 3 weeks.
b. 3 days a week for about 6 weeks.
c. 5 days a week for about 3 weeks.
d. 5 days a week for about 6 weeks.
14. Which chemotherapeutic agent is an RNA inhibitor?
b. mifepristone (RU486)
15. Meningioma patients experiencing headaches/nausea/vomiting are usually treated with
a. antiepileptic drugs.
b. antineoplastic drugs.
c. analgesics and antiemetics.
d. corticosteroids and analgesics.
16. The neuroscience nurse should teach all postsurgical meningioma patients about
a. the role of radiation therapy in assuring a good prognosis.
b. the ongoing need for frequent monitoring with imaging studies.
c. the importance of taking antiepileptic medications to prevent seizures.
d. the importance of taking corticosteroids for several months to prevent cerebral edema.
17. According to the authors, the majority of patients with intracranial meningiomas
a. can be cured.
b. can be managed but not cured.
c. will succumb to the effects of the tumor within 5 years.
d. will succumb to the effects of the tumor within 10 years.
18. The most common location of an intracranial meningioma is the
a. posterior fossa.
b. olfactory groove.
c. falx/parasagittal area.
d. intraventricular area.